{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:23:36Z","timestamp":1767853416654,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.anpede.2021.11.002","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T18:12:12Z","timestamp":1641406332000},"page":"59.e1-59.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunization schedule of the Pediatric Spanish Association: 2022 recommendations"],"prefix":"10.1016","volume":"96","author":[{"given":"Francisco Jos\u00e9","family":"\u00c1lvarez Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"\u00c1lvarez Alde\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Garc\u00e9s-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Garrote Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Iofr\u00edo de Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi\u00e1n","family":"Montesdeoca Meli\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Pineda Solas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Rivero Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepe","family":"Serrano Marchuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2021.11.002_bib0230","unstructured":"Centro Nacional de Epidemiolog\u00eda, Instituto de Salud Carlos III. Vigilancia epidemiol\u00f3gica de la Hepatitis B en Espa\u00f1a, 2019. Madrid. 2020; [accessed 30 Sep 2021]. Available from: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/Hepatitis%20B\/Vigilancia_HepatitisB_2019.pdf"},{"key":"10.1016\/j.anpede.2021.11.002_bib0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eimc.2014.12.010","article-title":"Vaccination against hepatitis B Impact of vaccination programmes after 20 years of use in Spain. Is it time for a change?","volume":"33","author":"Ar\u00edstegui Fern\u00e1ndez","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.anpede.2021.11.002_bib0240","first-page":"00777","article-title":"The optimal strategy for pertussis vaccination: a systematic review and meta-analysis of randomized control trials and real-world data","volume":"S0002-9378","author":"Nguyen","year":"2021","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.anpede.2021.11.002_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","article-title":"A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis","volume":"19","author":"Kandeil","year":"2020","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.anpede.2021.11.002_bib0250","doi-asserted-by":"crossref","first-page":"689394","DOI":"10.3389\/fimmu.2021.689394","article-title":"The effect of tetanus-diphtheria-acellular pertussis immunization during pregnancy on infant antibody responses: individual-participant data meta-analysis","volume":"12","author":"Abu-Raya","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.anpede.2021.11.002_bib0255","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3201\/eid2706.204238","article-title":"Twenty-year Public Health impact of 7- and 13-valent pneumococcal conjugate vaccines in US children","volume":"27","author":"Wasserman","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.anpede.2021.11.002_bib0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijid.2019.06.030","article-title":"Indirect effects of paediatric conjugate vaccines on invasive pneumococcal disease in older adults","volume":"86","author":"Ciruela","year":"2019","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0270","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3201\/eid2701.201178","article-title":"Post-13-valent pneumococcal conjugate vaccine dynamics in young children of serotypes included in candidate extended-spectrum conjugate vaccines","volume":"27","author":"Ben-Shimol","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0275","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.vaccine.2021.07.004","article-title":"A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age","volume":"39","author":"Klein","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2021.11.002_bib0280","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(20)30165-1","article-title":"Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study","volume":"21","author":"Ouldali","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1473-3099(20)30173-0","article-title":"Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study","volume":"21","author":"Desmet","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0290","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00431-020-03608-5","article-title":"Rotavirus vaccination for all children or subgroups only? Comment of the European Academy of Paediatrics (EAP) and the European Society for Paediatric Infectious Diseases (ESPID) recommendation group for rotavirus vaccination","volume":"179","author":"Dornbusch","year":"2020","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.anpede.2021.11.002_bib0295","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.anpedi.2019.06.001","article-title":"Recomendaciones para la vacunaci\u00f3n frente a ROTAvirus de los reci\u00e9n nacidos PREMaturos (ROTAPREM)","volume":"91","author":"\u00c1lvarez-Alde\u00e1n","year":"2019","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpede.2021.11.002_bib0300","doi-asserted-by":"crossref","first-page":"e210347","DOI":"10.1001\/jamapediatrics.2021.0347","article-title":"Association of rotavirus vaccines with reduction in rotavirus gastroenteritis in children younger than 5 years: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"175","author":"Sun","year":"2021","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.anpede.2021.11.002_bib0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Meningococcal group B vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0310","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.3390\/vaccines8030469","article-title":"Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014-2018)","volume":"8","author":"Azzari","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.anpede.2021.11.002_bib0315","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/jama.2020.20449","article-title":"Association of use of a meningococcus group B vaccine with group B invasive meningococcal disease among children in Portugal","volume":"324","author":"Rodrigues","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.anpede.2021.11.002_bib0320","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","article-title":"Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0325","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect."},{"key":"10.1016\/j.anpede.2021.11.002_bib0330","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3201\/eid2709.204866","article-title":"Invasive meningococcal disease 2011-2020, and impact of the COVID-19 pandemic, England","volume":"27","author":"Subbarao","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.anpede.2021.11.002_bib0335","year":"2021","journal-title":"2019-20 Season's Pediatric Flu Deaths Tie High Mark Set During 2017-18 Season"},{"key":"10.1016\/j.anpede.2021.11.002_bib0340","article-title":"Vaccines against influenza","year":"2012","journal-title":"WHO position paper \u2013 November"},{"key":"10.1016\/j.anpede.2021.11.002_bib0345","series-title":"ECDC scientific advice on seasonal influenza vaccination of children and pregnant women","year":"2012"},{"key":"10.1016\/j.anpede.2021.11.002_bib0350","article-title":"2.\u030a Estudio de Seroprevalencia en Espa\u00f1a, 2017-2018","volume":"95","author":"Limia S\u00e1nchez","year":"2021","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.anpede.2021.11.002_bib0355","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2015.06.009","article-title":"Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis","volume":"33","author":"Ma","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2021.11.002_bib0360","first-page":"CD004407","article-title":"Vaccines for measles, mumps, rubella, and varicella in children","volume":"4","author":"Di Pietrantonj","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.anpede.2021.11.002_bib0365","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.vaccine.2021.03.085","article-title":"Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries","volume":"39","author":"Prymula","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2021.11.002_bib0370","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of Herpes Zoster Among Children: 2003-2014","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpede.2021.11.002_bib0375","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00103-018-2791-2","article-title":"Background paper for the recommendation of HPV vaccination for boys in Germany","volume":"61","author":"Takla","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz."},{"key":"10.1016\/j.anpede.2021.11.002_bib0380","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.anpede.2021.11.002_bib0385","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000004000","article-title":"Human Papillomavirus Vaccination: ACOG Committee opinion, number 809","volume":"136","year":"2020","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.anpede.2021.11.002_bib0390","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jop.13091","article-title":"The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hospital-based population: A cross-sectional study of patient's registry","volume":"50","author":"Katz","year":"2021","journal-title":"J Oral Pathol Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-20-0846","article-title":"Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study","volume":"30","author":"Mix","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.anpede.2021.11.002_bib0400","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","article-title":"Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: A systematic review","volume":"16","author":"Harder","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0405","year":"2021","journal-title":"Actualizaci\u00f3n n\u00b0 508. Enfermedad por el coronavirus (COVID-19). 22.11.2021"},{"key":"10.1016\/j.anpede.2021.11.002_bib0410","year":"2021","journal-title":"COVID-19 en distintos entornos y grupos de personas"},{"key":"10.1016\/j.anpede.2021.11.002_bib0415","unstructured":"Instituto de Salud Carlos III. Informes COVID-19. [accessed 30 Sep 2021]. Available from: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Paginas\/InformesCOVID-19.aspx"},{"key":"10.1016\/j.anpede.2021.11.002_bib0420","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapediatrics.2020.4573","article-title":"Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared with Adults: A Systematic Review and Meta-analysis","volume":"175","author":"Viner","year":"2021","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.anpede.2021.11.002_bib0430","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.15585\/mmwr.mm6944e1","article-title":"Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020","volume":"69","author":"Grijalva","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.anpede.2021.11.002_bib0435","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0440","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109522","article-title":"Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents","author":"Ali","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0445","article-title":"Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age","author":"Walter","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.11.002_bib0450","author":"Shimabukuro","year":"2021","journal-title":"COVID-19 Vaccine safety updates. Advisory Committee on Immunization Practices (ACIP)"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287921002131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287921002131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:44:43Z","timestamp":1762422283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287921002131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2341287921002131"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2021.11.002","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization schedule of the Pediatric Spanish Association: 2022 recommendations","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2021.11.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}